Dan Boeding Email & Phone Number

San Francisco Bay Area

Responsible for the promotion of Auvelity for Major Depressive Disorder.

San Jose/Bay Area, California, United States

Responsible for the promotion of Caplyta for Schizophrenia and Bipolar Depression.- 2022 West Area Elevation Award Winner, for making the greatest impact on a territory. Q4 National ranking of 32/318 (Top 10%).

San Francisco Bay Area

- 2019 Cresset Gold Award (Recognizes Top 10% Nationally). Ranked in the Top 4% (11/301) for overall sales performance. - 2019 Q4 Pinnacle Award for Trintellix goal attainment (105%).

San Francisco Bay Area

Responsible for the successful launch (Aug. 2017) of Mydayis for ADHD, as well as the promotion of Vyvanse for ADHD and Binge Eating Disorder.

San Francisco Bay Area

Responsible for launching Rexulti (Atypical Antipsychotic), as well as the marketing and sales growth of Nuedexta in the San Francisco/Peninsula Territory. - Ranked 2nd for Rexulti Branded Market Share in the West Region through 11/11/2016.- Received Step Award for Exceeding 100% Sales Goal Attainment for both Rexulti and Nuedexta in Q1, 2016. One of only 2 territories to receive the award in the West Region.- Q1, 2016 Region Ranking, 9/37. Q2, 2016 Region Ranking 7/37.- Dramatically increased Sales for Rexulti during 2015 Launch. Increase in Sales Goal Attainment from 40% (launched 8/2015) to 109.3% by yeard end, 2015.

San Francisco

Execute sales and marketing of Abilify to Psychiatry and Primary Care providers in a 1 person, “Stand Alone” territory.- Ranked 17/59 (Top 29%) in the Region for final Performance Review (2012), before Otsuka took over sole responsibility for Abilify sales promotion.- Consistently delivered strong sales results in a territory where Abilify was disadvantaged due to its non-formulary status on the San Francisco County Formulary.- Received “Exceeds Expectations” for 2007, 2010 and 2011 Year End Performance Reviews.- Acting DBM, 2007. District Sales Trainer July, 2007- Nov., 2009. - Nominated to attend American Psychiatric Association Meeting (APA) in 2006 due to strong sales performance.- Received commendation from 2 Regional Business Directors and Associate Regional Business Director for exceptional field days with each of them (Aug., 2004, Mar., 2005, Sept. 2010).- National Alliance of Mental Illness (NAMI) Walk organizer for Bristol-Myers Squibb in the Bay Area, 2011. - Promoted to Neuroscience Specialty position, June, 2003, based on outstanding Sales Performance.

San Francisco

Responsible for selling Pravachol, Avapro and Cefzil to Cardiologists, Internal Medicine, General Practice, ENT’s and Pharmacies.- Pinnacle Ranking of 24 out of 110 (Top 22%).- Trained new hires on selling skills, product knowledge, territory management and corporate policies.

San Jose

Managed territory with annual sales of 1.7 million. Developed and maintained business with Fortune 500 firms in the technology and communications industries. Key customers included Apple and HP. ECT supplies test fixtures for use in in-circuit and functional test of printed loaded circuit boards.- Ranked 4th amongst worldwide sales force in sales to forecast for 2001.- 126% of 2001 goal, eligible to receive “Superstar Status” based on sales ranking.

San Francisco Bay Area

Specialized in selling Serzone, Buspar and Cefzil for the Neuroscience/Infectious Disease Division. Responsible for selling to Psychiatrists, Internal Medicine, General Practice, ENT’s and Pharmacies.- Ranked 55th in the nation out of 482 (top 11%) up until my final report in Nov, 1999, before leaving BMS.- Received “Excellence Award” 1998 from Regional Business Manager for outstanding sales performance.- Regional breakout facilitator for quarterly POA sales meeting, 1999.